These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22963629)

  • 1. Dendrimers and the development of new complex nanomaterials for biomedical applications.
    Gardikis K; Micha-Screttas M; Demetzos C; Steele BR
    Curr Med Chem; 2012; 19(29):4913-28. PubMed ID: 22963629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers.
    Gardikis K; Tsimplouli C; Dimas K; Micha-Screttas M; Demetzos C
    Int J Pharm; 2010 Dec; 402(1-2):231-7. PubMed ID: 20934501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Block copolymers for drug delivery nano systems (DDnSs).
    Kaditi E; Mountrichas G; Pispas S; Demetzos C
    Curr Med Chem; 2012; 19(29):5088-100. PubMed ID: 22963634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in dendrimer-based nanocarriers.
    Bai S; Thomas C; Rawat A; Ahsan F
    Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimers for pharmaceutical and biomedical applications.
    Yang H; Kao WJ
    J Biomater Sci Polym Ed; 2006; 17(1-2):3-19. PubMed ID: 16411595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology.
    Kontogiannopoulos KN; Assimopoulou AN; Hatziantoniou S; Karatasos K; Demetzos C; Papageorgiou VP
    Int J Pharm; 2012 Jan; 422(1-2):381-9. PubMed ID: 21979251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic systems in drug delivery applications.
    Jain NK; Asthana A
    Expert Opin Drug Deliv; 2007 Sep; 4(5):495-512. PubMed ID: 17880273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.
    Soliman GM; Sharma A; Maysinger D; Kakkar A
    Chem Commun (Camb); 2011 Sep; 47(34):9572-87. PubMed ID: 21655634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced drug delivery nanosystems (aDDnSs): a mini-review.
    Demetzos C; Pippa N
    Drug Deliv; 2014 Jun; 21(4):250-7. PubMed ID: 24134707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimers in biomedical applications--reflections on the field.
    Svenson S; Tomalia DA
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2106-29. PubMed ID: 16305813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable dendrimers for drug delivery.
    Huang D; Wu D
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():713-727. PubMed ID: 29853143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Advances in General Biomedical Applications of PAMAM Dendrimers.
    Araújo RV; Santos SDS; Igne Ferreira E; Giarolla J
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
    Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
    Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The seemingly trivial yet challenging synthesis of poly(aminoester) dendrimers.
    Wang Y; Quelever G; Peng L
    Curr Med Chem; 2012; 19(29):5011-28. PubMed ID: 22963630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery.
    Hu J; Su Y; Zhang H; Xu T; Cheng Y
    Biomaterials; 2011 Dec; 32(36):9950-9. PubMed ID: 21944725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.
    Yang H
    Nanomedicine; 2016 Feb; 12(2):309-16. PubMed ID: 26706410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
    Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
    Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An emerging class of amphiphilic dendrimers for pharmaceutical and biomedical applications: Janus amphiphilic dendrimers.
    Sikwal DR; Kalhapure RS; Govender T
    Eur J Pharm Sci; 2017 Jan; 97():113-134. PubMed ID: 27864064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the investigation of biological effect and surface modification of dendrimers as drug (gene) delivery systems].
    He ZH; Kong H; Xu HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):590-5. PubMed ID: 16995320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.